Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.
about
Antihistamines and birth defects: a systematic review of the literature.Safety of antihistamines during pregnancy and lactation.Assessment of antihistamine use in early pregnancy and birth defectsMaternal use of Loratadine during pregnancy and risk of hypospadias in offspringNo increased risk of infant hypospadias after maternal use of loratadine in early pregnancyThe ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine.A review of antihistamines used during pregnancyTreating allergic rhinitis in pregnancy.Use of antihistamine medications during early pregnancy and isolated major malformations.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.An approach to the patient with urticaria.Treatment of atopic dermatitis in pregnancy.The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.BSACI guideline for the management of chronic urticaria and angioedema.BSACI guidelines for the management of chronic urticaria and angio-oedema.The fetal safety of cetirizine: an observational cohort study and meta-analysis.Pregnancy: a therapeutic dilemma.Management and treatment of chronic urticaria (CU).
P2860
Q27348110-5E8E1D0D-3549-41FD-9752-3210B84A1AEFQ33846082-D16D703A-76F9-4A4E-9CBA-7F4E4327DBAAQ34075092-2C39C0D6-83BD-45EB-B631-2E518B93542FQ34485037-11B4271F-DB21-4641-81FC-C1A45F4F1A20Q34664924-D0C5EBE8-E179-48E3-AA43-D3246829E7C3Q35827475-360BBFC5-5CC8-4A14-9A4F-EA43DB6C7645Q35975200-33AFFDD5-D9AB-4E1E-9324-1364EE86B188Q36437216-403D4048-17FA-49E6-BD69-43D11CD104DAQ36747269-431F30BE-1B6E-4239-9317-9762DB2624F4Q36834774-D789001B-4DDE-4B6F-A33E-08E1F97309C9Q37247190-EB9BFB5A-6653-48BB-B144-1F6A006E3BD2Q38126535-E1B52B12-A304-4A58-8CFE-C4971BB48A7FQ39017678-D2D202E9-584E-4A88-9ADC-52186F7B0952Q39035835-BC758CA1-D8CB-44F1-8D6C-714B928778A1Q40220185-6917A8B3-8AE7-44CD-835A-6AF646E0F9BCQ47822479-A9F66139-31AA-4AA8-B0BA-D46473772DD1Q52673051-B3B328A8-19B9-4B66-8DA3-BA0F4972C673Q52938044-8798F997-BA24-44C8-8EEA-CB4FBAC5B008
P2860
Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@en
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@nl
type
label
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@en
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@nl
prefLabel
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@en
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@nl
P2093
P356
P1476
Pregnancy outcome after gestat ...... ctive controlled cohort study.
@en
P2093
Alona Aharonovich
Asher Ornoy
Judy Arnon
Larisa Moerman
Orna Diav-Citrin
Rebecka Wajnberg
Svetlana Shechtman
P304
P356
10.1067/MAI.2003.1499
P407
P577
2003-06-01T00:00:00Z